Skip to content

Prospective Data Collection of IVMRI Cases

Prospective Data Collection in Clinical Cases Where Coronary Plaque Lipid Characterization by IVMRI Was Performed During Diagnostic or Interventional Catheterization Procedures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00558441
Acronym
MIRACLE
Enrollment
1000
Registered
2007-11-15
Start date
2007-11-30
Completion date
2013-11-30
Last updated
2007-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Plaque Lipid Characterization

Brief summary

The study purpose is to prospectively collect data for a set of predefined variables in clinical cases where coronary plaque lipid characterization by IVMRI was performed during diagnostic or interventional procedures in order to gather incremental information beyond angiography and other diagnostic modalities.

Interventions

DEVICEIVMRI

Intra Vascular Magnetic Resonance Imaging

Sponsors

TopSpin Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* An adult patient ≥ 18 years old. * The patient, or legal guardian, has been informed of the nature of the study, agrees to its provisions, and has sign the approved informed consent. * The patient and the treating physician agree to attend the follow-ups as defined in the study protocol. * Indication for diagnostic and/or interventional procedure. * Lesions in a native vessels where IVMRI interrogation may provide additional information beyond angiography and other diagnostic tools.

Exclusion criteria

* Culprit lesions within 48 hours following STEMI. * Tortuous vessels, calcified or thrombotic lesions. * Significant stenosis of an unprotected left main coronary artery. * IVMRI interrogation of an unprotected left main coronary artery. * Patients with pacemaker or cardioverter defibrillator. * The patient is suffering from transplant mediated coronary artery disease.

Design outcomes

Primary

MeasureTime frame
LFI - Lipid Fraction Index5 years

Secondary

MeasureTime frame
correlation between LFI and a set of predefined parameters5 years

Countries

Israel

Contacts

Primary ContactSharon Sax
sharons@topspin.co.il+972-54-6603112

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026